Australia - English - Department of Health (Therapeutic Goods Administration)

luminarie pty ltd - vinorelbine tartrate, quantity: 110.8 mg (equivalent: vinorelbine, qty 80 mg) - capsule, soft - excipient ingredients: iron oxide yellow; macrogol 400; polysorbate 80; gelatin; purified water; titanium dioxide; partially dehydrated liquid sorbitol - non-small cell lung cancer: velabine is indicated for the first line treatment of advanced non-small cell lung cancer, as a single agent or in combination. ,breast cancer: velabine is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.

Namibia - English - Namibia Medicines Regulatory Council

teva pharmaceuticals (pty) ltd - vinorelbine tartrate - injection - each 1 ml vial contains; vinorelbine tartrate equivalent to vinorelbine 10,0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - vinorelbine tartrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg - soft gelatin capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide - first line treatment of advanced non-small cell lung cancer (nsclc) as a single agent or in combination

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg - soft gelatin capsule - 30 mg - active: vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide red macrogol 400 medium-chain triglycerides purified water   titanium dioxide - first line treatment of advanced non-small cell lung cancer (nsclc) as a single agent or in combination

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinorelbine tartrate 13.85 mg/ml equivalent to 10 mg/ml vinorelbine - solution for injection - 10 mg/ml - active: vinorelbine tartrate 13.85 mg/ml equivalent to 10 mg/ml vinorelbine excipient: water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk ltd - vinorelbine tartrate - concentrate for soln for inf - 10 mg/ml

Malta - English - Malta Medicines Authority

pierre fabre medicament 45 place abel gance, 92100 boulogne, france - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

Malta - English - Malta Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - vinorelbine tartrate - concentrate for solution for infusion - vinorelbine tartrate 10 mg/ml - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - vinorelbine tartrate - solution for infusion - 10mg/1ml